
Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning
Oncology Today with Dr Neil Love
00:00
Zuma 7 Trial
The first part is under, you know, getting experience with the drug and then getting experience and actually looking for it, right? You got to know about it before you're going in the room, right? How do you catch a plural fusion? Well, you actually have to listen to the lungs, right? There should be dullness at the basis if. All right, let's continue, I guess, another paper on metabolic tumor volume. We're kind of jumping now from our antibody drug conjugates to cellular therapy and this is looking at the Zuma 7 trial. And so just to refresh everybody's memory, this is Zuma 7.
Transcript
Play full episode